Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2009 Jun 05;28423:15980-92. doi: 10.1074/jbc.M809399200.
Show Gene links
Show Anatomy links
FRS2 via fibroblast growth factor receptor 1 is required for platelet-derived growth factor receptor beta-mediated regulation of vascular smooth muscle marker gene expression.
Chen PY
,
Simons M
,
Friesel R
.
???displayArticle.abstract???
Vascular smooth muscle cells (VSMC) exhibit phenotypic plasticity and change from a quiescent contractile phenotype to a proliferative synthetic phenotype during physiological arteriogenesis and pathological conditions such as atherosclerosis and restenosis. Platelet-derived growth factor (PDGF)-BB is a potent inducer of the VSMC synthetic phenotype; however, much less is known about the role of fibroblast growth factor-2 (FGF2) in this process. Here, we show using signal transduction mutants of FGF receptor 1 (FGFR1) expressed in rat VSMC that the adaptor protein FRS2 is essential for FGFR1-mediated phenotypic modulation and down-regulation of VSMC smooth musclealpha-actin (SMA) gene expression. In addition, we show that PDGF-BB and FGF2 act synergistically to induce cell proliferation and down-regulate SMA and SM22alpha in VSMC. Furthermore, we show that PDGF-BB induces tyrosine phosphorylation of FGFR1 and that this phosphorylation is mediated by PDGF receptor-beta (PDGFRbeta), but not c-Src. We demonstrate that FRS2 co-immunoprecipitates with PDGFRbeta in a complex that requires FGFR1 and that both the extracellular and the intracellular domains of FGFR1 are required for association with PDGFRbeta, whereas the cytoplasmic domain of FGFR1 is required for FRS2 association with the FGFR1-PDGFRbeta complex. Knockdown of FRS2 in VSMC by RNA interference inhibited PDGF-BB-mediated down-regulation of SMA and SM22alpha without affecting PDGF-BB mediated cell proliferation or ERK activation. Together, these data support the notion that PDGFRbeta down-regulates SMA and SM22alpha through formation of a complex that requires FGFR1 and FRS2 and prove novel insight into VSMC phenotypic plasticity.
Allen,
Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition.
2001, Pubmed
Allen,
Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition.
2001,
Pubmed
Andrae,
Role of platelet-derived growth factors in physiology and medicine.
2008,
Pubmed
Benjamin,
Platelet-derived growth factor stimulates growth factor receptor binding protein-2 association with Shc in vascular smooth muscle cells.
1994,
Pubmed
Brogi,
Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages.
1993,
Pubmed
Burgar,
Association of the signaling adaptor FRS2 with fibroblast growth factor receptor 1 (Fgfr1) is mediated by alternative splicing of the juxtamembrane domain.
2002,
Pubmed
Chen,
FGFR1 forms an FRS2-dependent complex with mTOR to regulate smooth muscle marker gene expression.
2009,
Pubmed
Chiara,
A gain of function mutation in the activation loop of platelet-derived growth factor beta-receptor deregulates its kinase activity.
2004,
Pubmed
Firulli,
A comparative molecular analysis of four rat smooth muscle cell lines.
1998,
Pubmed
Holycross,
Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation.
1992,
Pubmed
Larsson,
Fibroblast growth factor receptor-1-mediated endothelial cell proliferation is dependent on the Src homology (SH) 2/SH3 domain-containing adaptor protein Crk.
1999,
Pubmed
Lindner,
Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor.
1991,
Pubmed
Lindner,
Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries. An en face study.
1993,
Pubmed
Lindner,
Role of basic fibroblast growth factor and platelet-derived growth factor (B-chain) in neointima formation after arterial injury.
1995,
Pubmed
Lundgren,
Engineering the recruitment of phosphotyrosine binding domain-containing adaptor proteins reveals distinct roles for RET receptor-mediated cell survival.
2006,
Pubmed
Mack,
Regulation of smooth muscle alpha-actin expression in vivo is dependent on CArG elements within the 5' and first intron promoter regions.
1999,
Pubmed
Millette,
Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation.
2005,
Pubmed
Millette,
Platelet-derived growth factor-BB transactivates the fibroblast growth factor receptor to induce proliferation in human smooth muscle cells.
2006,
Pubmed
Mohammadi,
Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis.
1992,
Pubmed
Mood,
SNT1/FRS2 mediates germinal vesicle breakdown induced by an activated FGF receptor1 in Xenopus oocytes.
2002,
Pubmed
,
Xenbase
Muto,
Smooth muscle cell signal transduction: implications of vascular biology for vascular surgeons.
2007,
Pubmed
Neilson,
Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane, and kinase domains.
1996,
Pubmed
,
Xenbase
Ong,
FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors.
2000,
Pubmed
Ong,
Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins.
2001,
Pubmed
Ornitz,
FGFs, heparan sulfate and FGFRs: complex interactions essential for development.
2000,
Pubmed
Owens,
Molecular control of vascular smooth muscle cell differentiation and phenotypic plasticity.
2007,
Pubmed
Rauch,
Syndecan-4 is required for thrombin-induced migration and proliferation in human vascular smooth muscle cells.
2005,
Pubmed
Rzucidlo,
Regulation of vascular smooth muscle cell differentiation.
2007,
Pubmed
Sachsenmaier,
STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.
1999,
Pubmed
Saito,
Receptor heterodimerization: essential mechanism for platelet-derived growth factor-induced epidermal growth factor receptor transactivation.
2001,
Pubmed
Tanimoto,
Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells.
2004,
Pubmed
Thisse,
Functions and regulations of fibroblast growth factor signaling during embryonic development.
2005,
Pubmed
Vainikka,
Signal transduction by fibroblast growth factor receptor-4 (FGFR-4). Comparison with FGFR-1.
1994,
Pubmed
Wang,
Fibroblast growth factor receptors have different signaling and mitogenic potentials.
1994,
Pubmed
Xu,
Novel recognition motif on fibroblast growth factor receptor mediates direct association and activation of SNT adapter proteins.
1998,
Pubmed
Yang,
Sprouty genes are expressed in osteoblasts and inhibit fibroblast growth factor-mediated osteoblast responses.
2006,
Pubmed
Yoshida,
Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes.
2003,
Pubmed
